NK1 receptor antagonists--are they really without effect in the pain clinic?

Trends Pharmacol Sci. 2000 Dec;21(12):462-4; author reply 465. doi: 10.1016/s0165-6147(00)01578-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Aprepitant
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Humans
  • Morpholines / therapeutic use
  • Neurokinin-1 Receptor Antagonists*
  • Pain / drug therapy*
  • Piperidines / therapeutic use
  • Stereoisomerism

Substances

  • Morpholines
  • Neurokinin-1 Receptor Antagonists
  • Piperidines
  • 3-(2-methoxybenzylamino)-2-phenylpiperidine
  • Aprepitant